These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27284122)

  • 21. [Drug-induced hyperprolactinemia and galactorrhea].
    Bozzolo M; Haefeli WE; Noll G; Lüscher TF
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1511-3. PubMed ID: 1465520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia.
    Bhattacharjee S; Biswas R; Mandal N
    Indian J Psychiatry; 2021; 63(6):613-616. PubMed ID: 35136264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of sibutramine-induced hyperprolactinemia.
    Soares Leaes CG; Pereira-Lima JF; da Costa Oliveira M
    Neuro Endocrinol Lett; 2011; 32(5):616-8. PubMed ID: 22167128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitivity to paroxetine.
    Mera MT; Pérez BV; Fernández RO; Iglesias JF
    Allergol Immunopathol (Madr); 2006; 34(3):125-6. PubMed ID: 16858890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-related hyperprolactinemia.
    Prescrire Int; 2003 Feb; 12(63):18. PubMed ID: 12602384
    [No Abstract]   [Full Text] [Related]  

  • 26. [Verapamil-induced hyperprolactinemia--a case report].
    Krysiak R; Okopieh B; Herman ZS
    Pol Arch Med Wewn; 2005 Feb; 113(2):155-8. PubMed ID: 16209236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactorrhea during treatment with trimipramine. A case report.
    Wolfsperger M; Greil W
    Pharmacopsychiatry; 2005 Nov; 38(6):326-7. PubMed ID: 16342006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine-induced somnambulism.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin syndrome: case report and review of the literature.
    Weiner AL; Tilden FF; McKay CA
    Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
    Miller DE; Sebastian CS
    J Clin Psychiatry; 2005 Feb; 66(2):269-70. PubMed ID: 15705020
    [No Abstract]   [Full Text] [Related]  

  • 33. Case of gynecomastia during paroxetine therapy.
    Damsa C; Sterck R; Schulz P
    J Clin Psychiatry; 2003 Aug; 64(8):971. PubMed ID: 12927018
    [No Abstract]   [Full Text] [Related]  

  • 34. Paroxetine-induced excessive yawning.
    Harada K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):260. PubMed ID: 16594955
    [No Abstract]   [Full Text] [Related]  

  • 35. Paroxetine in the treatment of generalised anxiety disorder.
    Snyderman SH; Rynn MA; Bellew K; Rickels K
    Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of paroxetine on seizure length during electroconvulsive therapy.
    Curran S
    Acta Psychiatr Scand; 1995 Sep; 92(3):239-40. PubMed ID: 7484206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyponatremia upon resumption of paroxetine therapy.
    Wakita M; Matsuoka H; Hamada R; Okatsu H; Nakajima T; Osame M
    Intern Med; 2005 Mar; 44(3):240-2. PubMed ID: 15805714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxetine.
    Tang SW; Helmeste D
    Expert Opin Pharmacother; 2008 Apr; 9(5):787-94. PubMed ID: 18345955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression.
    Fagiolini A; Buysse DJ; Frank E; Houck PR; Luther JF; Kupfer DJ
    J Clin Psychopharmacol; 2001 Oct; 21(5):474-8. PubMed ID: 11593071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.